Podcast

  • 13. The regulatory code: In silico challenges

    Computer models and AI bring new opportunities and challenges. Tina Morrison, former FDA leader in regulatory science, shares insights from 15+ years advancing their use in healthcare regulation.

    Discover more
  • 12. Where data meets the scalpel

    We speak with Prof. Eric Vibert, a pioneering liver surgeon at Paris-Saclay, leading digital surgical innovation at Campus BOPEX, where clinicians and developers co-create tools to enhance precision and safety.

    Discover more
  • 11. How to talk about a revolution

    Marking our first podcast anniversary, in this episode our host Davide Montesarchio discusses with Martina Contin about why clear communication is key to engage with wider publics and build public trust.

    Discover more
  • 10. Beating bits: How AI can help cardiologists

    Dr. Elisa Rauseo joins to discuss how AI, machine learning, and in silico tools are transforming cardiology—and how prepared clinicians are to adopt these innovations in practice.

    Discover more
  • 9. Joints and bytes: Physics and the bones

    Kicking off 2025, we talk with Prof. Marco Viceconti, a pioneer in musculoskeletal applications—one of the most advanced frontiers of in silico medicine.

    Discover more
  • 8. A supercomputer and a digital heart

    In this episode we explore how in silico medicine is revolutionising cardiology with Mariano Vazquez from ELEM Biotech and the Barcelona Supercomputing Center

    Discover more
  • 7. Society’s role in shaping in silico medicine

    This episode features Zita van Horenbeeck, social scientist at the VPH Institute and PhD student at KU Leuven, discussing social implications and trust in in silico medicine.

    Discover more
  • 6. Ethics and the virtual human twin

    We speak with Michele Barbier, ethics expert for the European Commission and EU project coordinator at INRIA, about the ethical challenges of in silico medicine—from data privacy to equity and doctor-patient trust.

    Discover more
  • 5. Protecting privacy in the age of data

    Data is the backbone of in silico medicine. In this episode, Elisabetta Biasin, doctoral researcher at KU Leuven’s Centre for IT and IP Law, discusses how medical data must be managed to make it a reality.

    Discover more
  • 4. Exploring the world of in silico trials

    Drug development takes 10–15 years and costs millions, largely due to clinical trials. In this episode, Prof. Francesco Pappalardo explores how in silico methods can make the process faster, cheaper, and safer.

    Discover more
  • 3. The power of AI in medicine

    AI is transforming healthcare through in silico medicine. In this episode, Leonardo Castorina, PhD student at the University of Edinburgh, discusses AI’s origins and its role in enhancing doctors’ efficiency worldwide.

    Discover more
  • 2. Modelling medicine: How models work

    What are computer models, how are they built, and how can they improve healthcare? Himanshu Kaul, Royal Academy of Engineering Fellow at the University of Leicester, joins us to explain.

    Discover more